PL1796650T3 - Nanocząstki zawierające dostarczające podłoże - Google Patents

Nanocząstki zawierające dostarczające podłoże

Info

Publication number
PL1796650T3
PL1796650T3 PL05784613T PL05784613T PL1796650T3 PL 1796650 T3 PL1796650 T3 PL 1796650T3 PL 05784613 T PL05784613 T PL 05784613T PL 05784613 T PL05784613 T PL 05784613T PL 1796650 T3 PL1796650 T3 PL 1796650T3
Authority
PL
Poland
Prior art keywords
delivery vehicle
containing nanoparticles
vehicle containing
present
vehicles
Prior art date
Application number
PL05784613T
Other languages
English (en)
Inventor
Kerstin Ringe
Hans-Eckart Radunz
Katharina Landfester
Clemens Weiss
Original Assignee
Nanodel Tech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04027997A external-priority patent/EP1661559A1/en
Application filed by Nanodel Tech Gmbh filed Critical Nanodel Tech Gmbh
Publication of PL1796650T3 publication Critical patent/PL1796650T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
PL05784613T 2004-09-14 2005-09-14 Nanocząstki zawierające dostarczające podłoże PL1796650T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04021855 2004-09-14
EP04027997A EP1661559A1 (en) 2004-11-25 2004-11-25 Delivery vehicle manufactured by the miniemulsion method
EP05784613A EP1796650B1 (en) 2004-09-14 2005-09-14 Delivery vehicle containing nanoparticles
PCT/EP2005/009894 WO2006029845A2 (en) 2004-09-14 2005-09-14 Delivery vehicle containing nanoparticles

Publications (1)

Publication Number Publication Date
PL1796650T3 true PL1796650T3 (pl) 2009-06-30

Family

ID=35788673

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05784613T PL1796650T3 (pl) 2004-09-14 2005-09-14 Nanocząstki zawierające dostarczające podłoże

Country Status (11)

Country Link
US (1) US20070292524A1 (pl)
EP (1) EP1796650B1 (pl)
JP (1) JP2008513363A (pl)
CN (1) CN101072553A (pl)
AT (1) ATE419842T1 (pl)
CA (1) CA2579957A1 (pl)
DE (1) DE602005012289D1 (pl)
DK (1) DK1796650T3 (pl)
ES (1) ES2318531T3 (pl)
PL (1) PL1796650T3 (pl)
WO (1) WO2006029845A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713514B1 (en) * 2004-01-28 2021-11-24 Johns Hopkins University Drugs and gene carrier particles that rapidly move through mucous barriers
EP1815851A1 (en) * 2006-02-03 2007-08-08 NanoDel Technologies GmbH Nanoparticles designed for drug delivery
EP1876188A1 (en) * 2006-07-04 2008-01-09 NanoDel Technologies GmbH Two step miniemulsion process
EP2061433B1 (en) * 2006-09-08 2011-02-16 Johns Hopkins University Compositions for enhancing transport through mucus
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
US8512697B2 (en) * 2007-05-16 2013-08-20 The University Of North Carolina At Chapel Hill Delivery of micro- and nanoparticles with blood platelets
EP2271323A2 (en) 2008-05-06 2011-01-12 Glaxo Group Limited Encapsulation of biologically active agents
US8888736B2 (en) 2010-04-30 2014-11-18 H R D Corporation High shear application in medical therapy
BR112012027651A2 (pt) 2010-04-30 2016-08-16 H R D Corp método, e, sistema
WO2012074588A2 (en) 2010-08-30 2012-06-07 President And Fellows Of Harvard College Shear controlled release for stenotic lesions and thrombolytic therapies
EP2640426B1 (en) * 2010-11-16 2016-02-03 Selecta Biosciences, Inc. Immunostimulatory oligonucleotides
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
ES3055223T3 (en) 2012-05-03 2026-02-10 Alcon Inc Pharmaceutical nanoparticles showing improved mucosal transport
WO2013166487A1 (en) 2012-05-04 2013-11-07 Yale University Highly penetrative nanocarriers for treatment of cns disease
GB201304245D0 (en) * 2013-03-08 2013-04-24 Inst Quimic De Sarria Chemical compounds
CN104231137A (zh) * 2014-10-10 2014-12-24 河北科技大学 一种聚合物包埋疏水性抗肿瘤药物纳米复合微球的制备方法
KR101903536B1 (ko) * 2015-12-31 2018-10-02 후아웨이 테크놀러지 컴퍼니 리미티드 데이터 기입 방법, 장치, 및 시스템
KR20230088732A (ko) 2020-09-29 2023-06-20 옥스포드 유니버시티 이노베이션 리미티드 뇌졸중 치료
JP2022080126A (ja) * 2020-11-17 2022-05-27 三菱鉛筆株式会社 肥料粒子
PL247686B1 (pl) * 2023-02-21 2025-08-18 Inst Katalizy I Fizykochemii Powierzchni Im Jerzego Habera Polskiej Akademii Nauk Sposób wytwarzania wielordzeniowego nanonośnika polielektrolitowego syntetyzowanego na bazie siarczanu dodecylu sodu i wielordzeniowy nanonośnik polielektrolitowy do zastosowania do leczenia w terapii przeciwnowotworowej
CN116925337B (zh) * 2023-09-19 2023-12-01 广东药科大学 一种多巴胺衍生物的靶向型纳米载体构建的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5569509A (en) * 1979-11-30 1980-05-26 Mcleod Patrick Biologically decomposable particle
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
JPS6061521A (ja) * 1983-09-16 1985-04-09 Kyowa Hakko Kogyo Co Ltd マイクロカプセル化製剤
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
WO1995022963A1 (en) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Drug targeting system, method for preparing same and its use
CA2295177C (en) * 1997-06-13 2007-01-09 Medinova Medical Consulting Gmbh Drug targeting system, method of its preparation and its use
AUPO888097A0 (en) * 1997-08-29 1997-09-25 Biotech Australia Pty Limited Cross-linked particles
JP4272811B2 (ja) * 1997-09-05 2009-06-03 マルホ株式会社 関節内疾患治療用のナノカプセル製剤
FR2775435B1 (fr) * 1998-02-27 2000-05-26 Bioalliance Pharma Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
CA2445125A1 (en) * 2001-03-21 2002-10-03 University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
FR2841137B1 (fr) * 2002-06-20 2004-08-13 Bioalliance Pharma Systeme de vectorisation comprenant des nanoparticules de taille homogene d'au moins un polymere et d'au moins un polysaccharide charge positivement
ATE408398T1 (de) * 2002-07-29 2008-10-15 Nanodel Technologies Gmbh Nanopartikele für dna verabreichung zu einem zielorgan

Also Published As

Publication number Publication date
WO2006029845A3 (en) 2006-07-20
EP1796650A2 (en) 2007-06-20
EP1796650B1 (en) 2009-01-07
ES2318531T3 (es) 2009-05-01
DE602005012289D1 (de) 2009-02-26
DK1796650T3 (da) 2009-03-09
CN101072553A (zh) 2007-11-14
CA2579957A1 (en) 2006-03-23
US20070292524A1 (en) 2007-12-20
JP2008513363A (ja) 2008-05-01
ATE419842T1 (de) 2009-01-15
WO2006029845A2 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
PL1796650T3 (pl) Nanocząstki zawierające dostarczające podłoże
TWI315203B (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
WO2007085629A3 (en) Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
WO2009102467A3 (en) Devices, formulations, and methods for delivery of multiple beneficial agents
WO2005089106A3 (en) Degradable nanoparticles
MX2007010996A (es) Nuevas composiciones de liposomas.
NZ595313A (en) The Use Of Nanoparticles Comprising Rapamycin Or Taxane In The Treatment Of Proliferative Diseases
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
WO2004082628A3 (en) Improved bioavailability and improved delivery of acidic pharmaceutical drugs
WO2006018184A3 (de) Spirocyclische cyclohexan-derivate
WO2007098964A3 (en) Pyrrazole derivatives as sigma receptors antagonists
WO2007093975A3 (es) Uso del factor pedf para inducir la renovación de células
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
WO2006133707A3 (en) Anti-cancer combination treatment and kit-of-part
GB2446341A (en) Method and system for transdermal drug delivery
WO2010022031A8 (en) Topical hydrogel composition
IL195907A0 (en) Protein-binding methotrexate derivatives, and medicaments containing the same
WO2008051527A3 (en) Sustained release of agents for localized pain management
WO2007114946A3 (en) Acid-sensitive linkers for drug delivery
GB2443377A (en) Anti-malarial composition comprising artesunate and lumefantrine
GB0317491D0 (en) Organic compounds